ArticleKidney international reports2022

Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients.

Juliette Gueguen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.